Privia Health (PRVA) director sells 24,338 shares after option exercise

Rhea-AI Filing Summary

Privia Health Group, Inc. director Matthew Shawn Morris reported option exercises and related share sales. On February 26 and 27, 2026, he exercised stock options covering 24,338 shares of common stock at an exercise price of $2.00 per share.

He then sold 24,338 shares of common stock in open-market transactions at weighted average prices around $25.00 per share, executed under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, he directly owned 68,188 shares of common stock and held additional shares indirectly through a trust and Emerald Family, LLC.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morris Matthew Shawn

(Last) (First) (Middle)

PRIVIA HEALTH GROUP, INC.

950 N. GLEBE RD., SUITE 700

(Street)

ARLINGTON VA 22203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Privia Health Group, Inc. [ PRVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/26/2026		M(1)		7,788	A	$2	75,976	D
Common Stock, par value $0.01 per share	02/26/2026		S(1)		7,788	D	$24.99(2)	68,188	D
Common Stock, par value $0.01 per share	02/27/2026		M(1)		16,550	A	$2	84,738	D
Common Stock, par value $0.01 per share	02/27/2026		S(1)		16,550	D	$25(3)	68,188	D
Common Stock, par value $0.01 per share								11,998	I	By Trust
Common Stock, par value $0.01 per share								12,487	I	By Emerald Family, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Purchase)	$2	02/26/2026		M(1)			7,788	(4)	08/27/2033	Common Stock, par value $0.01 per share	7,788	$0	3,708,864	D
Stock Option (Right to Purchase)	$2	02/27/2026		M(1)			16,550	(4)	08/27/2033	Common Stock, par value $0.01 per share	16,550	$0	3,692,314	D

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.13 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.15 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

4. All of the stock options are fully vested and exercisable.

Remarks:

	/s/ Anita Beth Adams, as attorney-in-fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Privia Health (PRVA) report for Matthew Shawn Morris?

Privia Health director Matthew Shawn Morris exercised stock options for 24,338 shares at $2.00, then sold 24,338 common shares in open-market trades around $25.00 per share. These transactions occurred on February 26 and 27, 2026 under a Rule 10b5-1 trading plan.

How many Privia Health (PRVA) shares did the director sell and at what prices?

The director sold 24,338 Privia Health common shares in open-market transactions at weighted average prices near $25.00. Footnotes state individual trades occurred in ranges of $24.95–$25.13 and $24.95–$25.15 per share, with detailed breakdowns available on request.

What options did the Privia Health (PRVA) director exercise in this Form 4 filing?

He exercised fully vested stock options for a total of 24,338 shares of Privia Health common stock at an exercise price of $2.00 per share. These option exercises on February 26 and 27, 2026 were reported as derivative security conversions into common stock.

How many Privia Health (PRVA) shares does the director own after these transactions?

After the reported trades, the director directly owned 68,188 shares of Privia Health common stock. Additional indirect holdings included 11,998 shares held by a trust and 12,487 shares held by Emerald Family, LLC, as reflected in the Form 4’s ownership tables.

Was the Privia Health (PRVA) director’s stock sale under a Rule 10b5-1 plan?

Yes. The Form 4 footnotes state the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Such plans pre-schedule trades, allowing insiders to sell shares according to predetermined instructions regardless of later information.